Melasma: Treatment evaluation

Journal of Cosmetic and Laser Therapy

Volumn 11, Issue 3, 2009, Pages 146-150

  Salem, Ahmed ^a,b   Gamil, Hend ^a   Ramadan, Ali ^a   Harras, Mona ^a   Amer, Amin ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Hydroquinone; Melasma; Nd:YAG laser; Q switched; TCA

Indexed keywords

HYDROQUINONE; RETINOIC ACID; TRICHLOROACETIC ACID;

ADULT; APPARATUS; ARTICLE; CHLOASMA; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; EGYPT; FEMALE; HUMAN; LOW LEVEL LASER THERAPY; MALE; NEODYMIUM LASER; PRIORITY JOURNAL; SKIN ABRASION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; CAUSTICS; DERMATOLOGIC AGENTS; EGYPT; FEMALE; HUMANS; HYDROQUINONES; LASER THERAPY, LOW-LEVEL; LASERS, SOLID-STATE; MALE; MELANOSIS; SEVERITY OF ILLNESS INDEX; TRICHLOROACETIC ACID;

EID: 68849103414     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.1080/14764170902842549     Document Type: Article

References (17)

1. Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453-1457
2. Prignano F, Ortonne JP, Buggiani G, Lotti T. Therapeutic approaches in melasma. Dermatol Clin. 2007;25:337-342
3. Keeling J, Cardona L, Benitez A, Epstein R, Rendon M. Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature. Cutis. 2008;81:179-183
4. Grimes PE. An efficacy study of three commercially available hydroquinone 4% treatments for melasma. Cutis. 2007;80:497.
5. Khunger N, Sarkar R, Jain R. Tretinoin peels versus glycolic acid peels in the treatment of melasma in dark skinned patients. Dermatol Surg. 2004;30:756-760 (Pubitemid 38657969)
6. Lawrence N, Cox SE, Brody HJ. Treatment of melasma with Jessners solution verus glycolic acid: a comparison of clinical efficacy and evaluation of the predicive ability of Wood's light examination. J Am Acad Dermtol. 1997;36:589-593 (Pubitemid 27164492)
7. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55:1048-1065 (Pubitemid 44716465)
8. Rusciani R, Motta A, Rusciani L, Alfano C. Q-switched alexandrite laser-assisted treatment of melasma: 2-year follow-up monitoring. J Drugs Dermatol. 2005;4:770-779
9. Kimbrough-Green CK, Griffiths CM, Finkel LJ, Hamilton TA, Bulengo-Ranshy SM, Ellis CN, Voorhees JJ. Topical retinoic acid (tretinoin) for melasma in black patients. Arch Dermatol. 1994;130:727.
10. Hexsel D, Arellano I, Rendon M. Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation. Br J Dermatol. 2007;156:7-12. (Pubitemid 44809123)
11. Sanchez J, Vazquez M. A hydroquinone solution in the treatment of melasma. Int J Dermatol. 1982;21:55-58.
12. Glenn M, Grimes PE, Pitt E, Chalet M, Kelly AP. Evaluation of clinical and light microscopic effects of various concentrations of hydroquinone. Clin Res. 1991;39:83A.
13. Tsai T, Bowman P, Jee S, Maibach H. Effects of glycolic acid on light-induced skin pigmentation in Asian and Caucasian subjects. J Am Acad Dermatol. 2000;43:238-243 (Pubitemid 30626000)
14. Lee GY, Kim HJ, Whang KK. The effects of combination treatment of recalcitrant pigmentary disorders with pigmented laser and chemical peeling. Dermatol Surg. 2002;28:1120-1123
15. Karasi S, Raulin C. Fractional photothermolysis: a new option for treating melasma? Hautartzt. 2008;59:92-100.
16. Kilmer SL, Wheeland RG, Goldberg DJ, Andveson R. Treatment of epidermal pigmented lesions with the frequency doubled Q-switched Nd:YAG laser. A controlled, single-impact, response, multicenter trial. Arch Dermatol. 1994;130:1515-1519
17. Taylor CR, Anderson RR. Ineffective treatment of melasma and post inflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol. 1994;20:592-597